Equasens: Changes in the Equasens Group Executive Committee Villers-lès-Nancy, 27 December 2023 - 6:00 p.m. (CET)PRESS RELEASE Changes in...
EQUASENS: Acquisition of the German company ADV and creation of PHARMAGEST Germany Villers-lès-Nancy, 23 November 2023 - 6:00 p.m. (CET...
EQUASENS : Chiffre d’affaires du 3ème trimestre 2023 Villers-lès-Nancy, le 9 novembre 2023 - 18h00 (CET) COMMUNIQUE DE PRESSE Chiffre...
EQUASENS : Mise à disposition du Rapport Financier Semestriel 2023 Villers-lès-Nancy, le 4 octobre 2023 - 18h00 (CET) COMMUNIQUE DE PRESSE...
EQUASENS: H1 2023 Results Villers-lès-Nancy, 29 September 2023 - 6:00 p.m. (CET) PRESS RELEASE H1 2023 Results Growth momentum bolstered...
EQUASENS : bilan du contrat de liquidité au 30 juin 2023 Villers-lès-Nancy, le 25 septembre 2023 - 18h00 (CET) COMMUNIQUE DE PRESSE BILAN...
EQUASENS GROUP: H1 2023 revenue: up 9% to €112.62m Villers-lès-Nancy, 3 August 2023 - 6:00 p.m. (CET) PRESS RELEASE H1 2023 revenue:up 9...
EQUASENS: results of the votes on the resolutions submitted to the ordinary annual shareholders' meeting of 29 june 2023...
EQUASENS : ASSEMBLEE GENERALE ORDINAIRE ANNUELLE - AVIS DE CONVOCATION - MISE EN LIGNE DES DOCUMENTS PREPARATOIRES Villers-lès-Nancy, le 9...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.